The site of ribosome stalling in the leader ofcat transcripts is critical to induction of downstream translation.
inducers are the antibiotics to which the genes confer resistance, chloramphenicol and erythromycin, respectively. Induction results from the stalling of a ribosome at a highly specific site in the leader region of the transcripts. This stall site places the ribosome at the correct location to destabilize downstream secondary structure and activate translation of the drug resistance gene (11) .
The inducers of cat and enn genes are sequence-independent inhibitors of ribosome elongation, yet induction depends on site-specific ribosome stalling. This apparent contradiction was resolved by the finding that within the cat-86 leader there exists a signal that determines the site of ribosome stalling. This signal is specified by leader codons 2 through 5, the crb sequence (23) , and enables chloramphenicol to stall a ribosome with its aminoacyl site at leader codon 6 (Fig. 1) . In a search for the basis of the stalling specificity, we observed that crb is largely complementary to a sequence in 16S rRNA of Bacillus subtilis (22) . While base pair formation between crb and rRNA may contribute to the specificity of stalling, four synonymous codon changes within crb reduced by less than half the inducibility of cat-86 by chloramphenicol (22) . Since these codon changes virtually eliminated the proposed crb-anti-crb pairing, it is evident that some other aspect of crb must be the primary determinant of stalling specificity during chloramphenicol induction.
Missense mutations in crb which should have little effect on the pairing of leader mRNA with 16S rRNA can abolish induction (4) . Moreover, a change-of-frame mutation 5' to crb prevents induction, whereas a similar mutation immediately 3' to crb does not (23) . Given these findings, it seemed likely that site-specific ribosome stalling would depend on an * Corresponding author.
activity of the leader-encoded peptide. We here demonstrate that the cat-86 nascent leader peptide inhibits a ribosome activity necessary for elongation.
MATERIALS AND METHODS
Peptidyl transferase. The fragment reaction was used to assay peptidyl transferase activity (19) . Reaction mixes consisted of 60 mM Tris-HCl (pH 7.4), 400 mM KCI, 20 mM magnesium sulfate, and 1 mM neutralized puromycin in 50 ,ul, to which was added 25 ,ul of absolute ethanol. Unless specifically noted, 70S ribosomes purified from B. subtilis BR151 as described by Spedding (25) were added to 0.55 p,M. 35S-labeled N-formylmethionine, charged to tRNA and digested with endonuclease Ti as described by Marcker (16) , was added to each reaction at 1 x 106 to 2 x 106 cpm. Analysis of these preparations by using high-voltage paper electrophoresis demonstrated that about one-half of the radioactivity was in the N-formylmethionine-T1 fragment, with the remainder distributed between free methionine and N-formylmethionine.
Peptide inhibitors were typically preincubated with the ribosomes prior to addition to the other reactants, as noted in the text. Antibiotic inhibitors such as chloramphenicol were added to reaction mixes with the ribosomes but without the preincubation step. Preincubation of ribosomes with chloramphenicol failed to increase its inhibitory effect on peptidyl transferase, whereas peptide inhibition was greatly enhanced by the preincubation step. Peptidyl transferase reaction mixes were incubated on ice for 1 h, except where noted otherwise, and reactions were terminated by addition of 50 p,l of 0.3 M sodium acetate saturated with magnesium sulfate followed by 1 ml of ethyl acetate. The ethyl acetate phase was counted for radioactivity. All peptidyl transferase assays were performed in duplicate or triplicate, and the replicates varied by less than 5%. In separate experiments, the inhibitory activity of a single peptide preparation on a single ribosome preparation varied by as much as 10%. The inhibitory activity associated with a single preparation of 5-mer peptide varied somewhat when assayed on different ribosome preparations (see text), whereas different preparations of 5-mer peptide showed similar inhibitory activities (±10%) when assayed on a single ribosome preparation.
Peptides. Peptides were synthesized by the University of Maryland Core Facility; Biosynthesis, Inc., Lewisville, Tex.; or Research Genetics, Huntsville, Ala., with the exception of the dipeptide MV, which was purchased from Sigma. As obtained, the peptides were greater than 80% homogeneous. All peptides were purified further by reversephase high-pressure liquid chromatography, using as the solvent 20% methanol-0.25% acetic acid in water. Purified peptides were lyophilized, and stock solutions were prepared in ribosome buffer (25) . Selected peptides were analyzed either by N-terminal sequencing or by determining total amino acid composition. In each case, the results obtained were consistent with the reported amino acid sequence.
RESULTS
Induction of cat-86 by chloramphenicol requires translation of the first five leader codons ( Fig. 1) (1, 7) . If the leader N-terminal pentapeptide (the 5-mer) paused the translating ribosome at the induction site, this would increase the probability that upon addition of chloramphenicol, the antibiotic would rapidly contact ribosomes poised for induction.
In this model, the nascent peptide would interfere with elongation by the ribosome that has just completed its translation. Therefore, inhibition in vivo should be an intramolecular event. To test the model, it was assumed that the inibition could be detected in a bimolecular reaction. We directed our studies to peptidyl transferase, since this activity is the site of action of several ribosomally targeted antibiotics (18) .
Peptidyl tnfese. Peptidyl transferase is a catalytic activity present within the large subunit of ribosomes (18) .
The activity has been associated with 23S rRNA and is the target for inhibition by the antibiotic chloramphenicol (18, 20 MVKTD. The preincubation mixes were diluted into reaction cocktails to assay for residual peptidyl transferase activity (Fig. 4) . Under these conditions, the 4-mer failed to significantly inhibit the reaction, whereas the 5-mer was an effective inhibitor. To determine whether inhibition by the 5-mer was sequence specific, the five-residue peptide MVKTD was synthesized in reverse amino acid sequence, DTKVM. This reverse 5-mer had no detectable inhibitory activity toward peptidyl transferase under conditions in which the 5-mer reduced the activity by up to 93%. The time of preincubation of ribosomes with peptide influenced the extent of inhibition by the 4-and 5-mers (Fig.  5) . However, even prolonged preincubation of ribosomes with the reverse 5-mer failed to significantly inhibit peptidyl transferase. From these data, we infer that 5-mer inuhibition depends on a specific sequence of amino acids, or types of amino acids, in the peptide and that this sequence is absent in the reverse orientation. Fig. 4 the mutation. Replacing leader codon 4 (ACA) with a Pro (CCA) codon abolishes induction by chloramphenicol, whereas replacement of leader codon 2 (GTG) with an Ala codon (21) does not detectably interfere with induction. Peptides with these amino acid substitutions showed different activities toward peptidyl transferase (Fig. 6 ). The Ala substitution had no significant effect on 5-mer inhibition, while the Pro substitution relieved essentially all inhibition.
The SOS subunit contains the target for the 5-mer peptide. Peptidyl transferase activity resides in the 50S subunit of bacterial ribosomes (19, 20) . To determine whether 5-mer inhibition was due to direct interaction with the catalytic (50S) subunit or required the 30S portion, ribosomes were dissociated (25) and the 30S and 50S subunits were individually tested for peptidyl transferase and its response to the 5-mer (Table 1 ). All peptidyl transferase activity of the dissociated ribosomes was due to the SOS subunits, and incubation of the 50S subunits with the 5-mer peptide resulted in inhibition that was approximately twice that observed with the 70S ribosomes. However, the 4-mer and the reverse 5-mer had little effect on the peptidyl transferase activity of the 50S subunits.
The increased response of peptidyl transferase activity of the 50S subunit to inhibition by the 5-mer was consistently observed. It is not yet known whether this finding indicates that the 30S subunit itself interferes with attachment of the peptide to the ribosome or whether the conformation of the 70S ribosome causes it to be relatively insensitive to exogenously added peptide.
DISCUSSION
The evidence that we have obtained demonstrates that a peptide corresponding to the first five codons of the cat-86 regulatory leader is inhibitory for peptidyl transferase. Peptides corresponding to the first two, three, or four leader codons show no significant inhibitory activity. Thus, when a ribosome has translated to the leader site necessary for induction, it has simultaneously synthesized an inhibitor of ribosome elongation. We presume that in vivo, the nascent 5-mer promotes stalling specificity by causing a ribosome to pause at the induction site. Conversion of the paused state to a stalled condition or perhaps to a dead-end complex (21) might be a function of chloramphenicol. This model can explain the site specificity of ribosome stalling and provides a likely explanation for the sensitivity of induction to very low levels of the antibiotic inducer. Ribosome pausing in the leader, dictated by the activity of the 5-mer, should result in ribosomes preferentially occupying the induction site. By this reasoning, ribosomes in the leader that are contacted by chloramphenicol will preferentially be those poised for induction. Our results do not eliminate the alternative explanation that the 5-mer blocks ribosome elongation only after movement of the translating ribosome is slowed by chloramphenicol. However, if this is the case, it offers no explanation for the elevated sensitivity to chloramphenicol of the induction mechanism relative to overall protein synthesis inhibition by the antibiotic. Clearly, both explanations suppose that the 5-mer acts in cis on the ribosome that has just completed its translation.
The activity of the 5-mer against peptidyl transferase does not in itself indicate that the peptide directly contacts the enzyme (or ribozyme [20] Previous studies of several examples of transcription attenuation offer no indication that the leader peptide has a function that is essential to the regulation (14) . The role of the leader seems limited to providing a sequence that allows a ribosome to translate through a potential stall site, with stalling being dependent on the absence of a metabolite. In contrast, genes regulated by translation attenuation respond to inducers that block ribosome elongation but not in the sequence-dependent manner that is clearly necessary for the regulation. Previously reported genetic evidence (15) has argued for a function of the cat-86 leader peptide in the regulation, and our present findings appear to identify the biological function of the peptide as the determinant of the site of ribosome stalling. Other regulated cat genes show similarity to cat-86 with respect to the sequence and spatial organization of the leader (2, 3, 9, 12, 24) . We therefore suspect that the observations made with the cat-86 5-mer peptide may apply to the leader pentapeptides of other inducible cat genes. Indeed, genetic studies suggest a role for the erm leader peptide in erythromycin-inducible regulation (6, 17) , and it will be of interest to determine whether the erm peptides make a contribution to erythromycin-inducible regulation similar to the one that we propose for the cat-86 leader peptide.
The proposal for ribosome regulation by a nascent peptide is not without precedent. The nascent N-terminal tetrapeptide of ,B-tubulin has been shown to influence the activity of the tran'slating ribosome, determining whether the ribosome continues translation or degrades the mRNA (10) . Similarly, ribosome hopping during the translation of the topoisomerase gene of bacteriophage T4 depends on a function of the nascent peptide upstream from the site of the hop (26) . Observation of the effects of nascent peptides on translation may be limited to situations in which the peptide contributes to controlling gene expression in an obvious manner. Whether nascent peptides can, in general, communicate with the translating ribosome to cause subtle changes in translation rates is difficult to determine. However, the inhibition of a known ribosome-associated, catalytic activity by the cat-86 leader peptide provides one biochemical mechanism through which a nascent peptide can modify the function of the translating ribosome.
